Preparation and quality evaluation of divided medicinal powders containing captopril for pediatric use
DOI:
https://doi.org/10.30968/rbfhss.2017.084.008Keywords:
Pediatria, captopril, pós medicamentosos divididosAbstract
Background: Pediatric patients require different dosage forms from adults due to differences in swallowing capacities, taste preferences, and dosage requirements. Most medicines are produced for adults as capsules and tablets. These formulations are not suitable for children, which often leads to off-label and unlicensed use of adult medicines. These preparations are often prescribed by pediatricians due to the absence of others replace them. In this context, consider the drug preparation in another pharmaceutical dosage form is the responsibility of the pharmacist.Objectives: the aim of the present study was to design solid dosage forms containing captopril for prior solubilization in small volumes of water before administration. Solid dosage forms are more stable than liquids and the reconstituted solutions can be sweetened and flavored
Methods: quality control tests were performed in the captopril and in the each batch of dosage forms in accordance with official and validated methods. The formulations were compounded by geometric dilution.
Results: captopril complied with the pharmacopoeial requirements (aspect, identification, pH, solubility, and melting point). The use of compressible sucrose and sorbitol as singles diluents, as well as the combination thereof with lactose M200, originated solutions clear, without particles in suspension, and sweetened. The divided powders were approved in the quality assays (average weight, dose uniformity and drug content).
Conclusions: according with the results, it was possible to prepare medicated powders containing 6.25 mg of captopril, with intention to minimize the lack of existing antihypertensive pediatric formulations in the national market.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
The authors hereby transfer, assign, or otherwise convey to RBFHSS: (1) the right to grant permission to republish or reprint the stated material, in whole or in part, without a fee; (2) the right to print republish copies for free distribution or sale; and (3) the right to republish the stated material in any format (electronic or printed). In addition, the undersigned affirms that the article described above has not previously been published, in whole or part, is not subject to copyright or other rights except by the author(s), and has not been submitted for publication elsewhere, except as communicated in writing to RHFHSS with this document.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-NC-ND) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Serlf-archiving policy
This journal permits and encourages authors to post and archive the final pdf of the articles submitted to the journal on personal websites or institutional repositories after publication, while providing bibliographic details that credit its publication in this journal.
